World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
33691
World Ranking
1539
National Ranking
28

Medicine

D-Index
81
Citations
33691
World Ranking
16421
National Ranking
689

Jean-Pierre Routy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Pierre Routy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 545 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Pierre Routy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Pierre Routy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jean-Pierre Routy is affiliated with the McGill University Health Centre in Canada. Their research primarily focuses on medicine, immunology, and microbiology, with a significant output in HIV research and treatment alongside related fields.

Their main fields of study include:

  • Medicine
  • Immunology and Microbiology

Subfields that Routy has extensively contributed to are:

  • Immunology
  • Virology
  • Infectious Diseases
  • Epidemiology
  • Emergency Medicine

Research topics covered in Routy's work include:

  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Cytomegalovirus and herpesvirus research
  • T-cell and B-cell Immunology

Routy has coauthored numerous publications with frequent collaborators such as Stéphane Isnard, Petronela Ancuța, Cécile Tremblay, Cecilia T. Costiniuk, and John Lin.

Their frequent publication venues include:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • AIDS
  • EBioMedicine

Notable recent papers authored or coauthored by Routy include:

  • Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo (2020, Nature)
  • Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study (2020, Clinical Infectious Diseases)
  • Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System (2020, Frontiers in Immunology)
  • The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation (2020, Frontiers in Immunology)
  • Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART (2020, Nature Communications)

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

    Nicolas Chomont;Mohamed El-Far;Petronela Ancuta;Lydie Trautmann

  • Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction

    Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said

  • Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

    Susan J. Little;Sarah Holte;Jean Pierre Routy;Eric S. Daar

  • High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

    Bluma G Brenner;Michel Roger;Jean-Pierre Routy;Daniela Moisi

  • Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection

    Elias A. Said;Franck P. Dupuy;Lydie Trautmann;Yuwei Zhang

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity

    Souheil Antoine Younes;Bader Yassine-Diab;Alam R. Dumont;Alam R. Dumont;Mohamed Rachid Boulassel

  • Interleukin-2 therapy in patients with HIV infection.

    D. Abrams;Y. Lévy;M. H. Losso;A. Babiker

  • Peripheral Blood CCR4 + CCR6 + and CXCR3 + CCR6 + CD4 + T Cells Are Highly Permissive to HIV-1 Infection

    Annie Gosselin;Patricia Monteiro;Nicolas Chomont;Felipe Diaz-Griffero

  • Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

    Samantha Reiss;Amy E. Baxter;Kimberly M. Cirelli;Jennifer M. Dan;Jennifer M. Dan

  • HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation

    Marie Lise Dion;Jean François Poulin;Rebeka Bordi;Myriam Sylvestre

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.

    Christopher C. Nixon;Maud Mavigner;Gavin C. Sampey;Alyssa D. Brooks

  • Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study.

    Jean van Wyk;Faïza Ajana;Fiona Bisshop;Stéphane De Wit

  • Interleukin-7 promotes HIV persistence during antiretroviral therapy

    Claire Vandergeeten;Rémi Fromentin;Sandrina DaFonseca;Mariam B. Lawani

  • Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.

    Bluma G. Brenner;Jean-Pierre Routy;Marco Petrella;Daniela Moisi

  • Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells

    Hendrik Streeck;Jonathan S. Jolin;Ying Qi;Bader Yassine-Diab

  • Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users

    Katharine J. Bar;Hui Li;Annie Chamberland;Cecile Tremblay

  • Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.

    Philippe Bégin;Jeannie Callum;Erin Jamula;Richard Cook

  • Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

    L. Trautmann;L. Janbazian;N. Chomont;E. A. Said

  • Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation: An observational cohort study.

    Song Chen;Xi-En Gui;Qian Cao;Jean-Pierre Routy

Frequent Co-Authors

Nicolas Chomont
Nicolas Chomont University of Montreal
Petronela Ancuta
Petronela Ancuta University of Montreal
Rafick P. Sekaly
Rafick P. Sekaly Emory University
Pierre Côté
Pierre Côté University of Ontario Institute of Technology
Mark A. Wainberg
Mark A. Wainberg McGill University
Taisheng Li
Taisheng Li Peking Union Medical College Hospital
Bluma G. Brenner
Bluma G. Brenner McGill University
Rémi Fromentin
Rémi Fromentin University of Montreal
Marina B. Klein
Marina B. Klein McGill University
Susan J. Little
Susan J. Little University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students interested in clinical applications may explore nursing paths that complement immunology knowledge, such as Licensed Practical Nurse (LPN) programs. For those seeking accessible entry points, the best easiest lpn programs to get into offer practical routes into nursing with flexible online options.

Advancing further, Nurse Practitioner (NP) programs provide a more specialized clinical role. Those balancing study with other commitments often look for the easiest np program that maintains quality while offering manageable coursework.

For graduates interested in mental health, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are an exciting path. Online options like the best psychiatric mental health nurse practitioner programs online provide strong clinical placement opportunities, crucial for hands-on experience.

Cost is also a critical factor. Many students prioritize affordability, and programs listed as the cheapest online pmhnp programs make advanced nursing education accessible without compromising quality.

Exploring these related degrees and career pathways can enhance an Immunology background, offering versatile options for working in healthcare, research, and specialized clinical settings.

Best Scientists Citing Jean-Pierre Routy

Trending Scientists

Recently Published Articles